Drug Type Small molecule drug |
Synonyms BMS-184919, BMS-184920, BMS-186282 + [1] |
Target |
Action inhibitors |
Mechanism thrombin inhibitors(Factor IIa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC25H36N6O5S |
InChIKeyXEEMSMVEWYEKLY-VOQZNFBZSA-N |
CAS Registry162167-00-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thromboembolism | Discovery | United States | - |